Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
INSEAD Network
82 CONNECTIONS
Venrock Network
21 CONNECTIONS
cb
Investing Profile

Anders Hove

VCFounderInvestor
Partner and Founder at Acorn Bioventures
acornbioventures.comNew York, New York
$100K - $5.0M
$1.5M
21
CompanyStageDateRound SizeTotal Raised
Intuity Medical
Series UnknownNov 2016$40M
Series UnknownJan 2014$6M
Series UnknownAug 2012$12M
Series DAug 2011$12M
Series DJan 2010$64M
$220M
Co-investors: Casey Tansey (U.S. Venture Partners (USVP)), Eric Aguiar (Aisling Capital), Scott Bluestein (Hercules Capital)
Edge Therapeutics
Series CApr 2015$56M
$56M
Co-investors: James Healy (Sofinnova Investments)
Mevion Medical Systems
Private EquityAug 2014$200M
Private EquityJun 2013$55M
Series UnknownJan 2012$45M
Series UnknownJan 2009$33M
Series COct 2007$7M
$340M
Coherus Biosciences
Series CMay 2014$55M
$55M
Virdante Pharmaceuticals
Series ANov 2009$30M
$30M
Anacor Pharmaceutical
Series EJan 2009$50M
Series CMay 2005$25M
$87M
Co-investors: Paul Klingenstein (Aberdare Ventures), Ling Wong (Highbury Group)
PEAK Surgical
Series CFeb 2008$21M
Series BSep 2006$8M
$29M
Adnexus
Series CAug 2007$16M
Series BJun 2006$27M
$56M
Co-investors: Alan Crane (Polaris Partners), Noubar Afeyan (Flagship Ventures)
Managing General Partner Venrock2004 - 2016
Portfolio manager of BB Biotech & CEO of Bellevue Asset Management Bellevue Asset Management1996 - 2003
Project Manager Novartis1992 - 1996
INSEAD Master of Business Administration (MBA) Finance, General
Københavns Universitet Doctor of Medicine (M.D.) Biology, General
Danmarks Tekniske Universitet Master of Science (MSc) Biotechnology